Who has invested in Epsilogen?

Epidarex Capital are named among the investors backing Epsilogen.

Epsilogen Funding: $60M Raised, Series B (2024)

Epsilogen funding overview

Epsilogen is a Biotech company based in London, United Kingdom. Epsilogen has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for Epsilogen runs through 2024; nothing later has been disclosed. Investors on record include Epidarex Capital.

Epsilogen at a glance

Total raised: $60M
Latest round: Series B
Latest round date: September 2024
Industry: Biotech
Headquarters: London, United Kingdom
Notable investors: Epidarex Capital

Frequently asked about Epsilogen funding

How much has Epsilogen raised?: Epsilogen has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Epsilogen?: Epidarex Capital are named among the investors backing Epsilogen.
What was the latest Epsilogen funding round?: The most recent disclosed round is a Series B, announced in September 2024.
Where is Epsilogen based?: Epsilogen is based in London, United Kingdom.
What sector does Epsilogen operate in?: Epsilogen is tracked under Biotech from London, United Kingdom, with $60M in disclosed funding.
When did Epsilogen last raise?: The last disclosed Epsilogen round closed in September 2024 at Series B.

We update the Epsilogen record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related Biotech companies in London and their backers are listed below.

Epsilogen Funding: $60M Raised, Series B (2024)

Epsilogen funding overview

Epsilogen at a glance

Frequently asked about Epsilogen funding

Epsilogen founders (1)

Companies related to Epsilogen (40)

Browse related funding lists (5)